Fatemeh Ardeshir, Andrew Srisuwananukorn receive ECOG-ACRIN Awards of Distinction

ECOG-ACRIN, Caris collaborate on interrogating TAILORx breast cancer trial

ECOG-ACRIN Cancer Research Group and Caris Life Sciences announced a multi-year research collaboration wherein Caris is pairing its genomic, transcriptomic, and proteomic profiling, advanced artificial intelligence and machine learning algorithms with ECOG-ACRIN’s research capabilities.

October 25, 2024

Vol.50 No.40

Clinical

Randomized trial failed to accrue, but data point to preoperative chemo as viable option in sinonasal cancer

If clinical research were anything like fly fishing, the scientific question that EA3163 trial attempted to answer might be considered “the one that got away”.

Group chairs propose funding strategy to jump-start correlative studies

The National Academy of Medicine recognized the value of correlative science in publicly funded clinical trials in 2010, recommending “the incorporation of innovative science into cancer clinical trials through the support and use of biorepositories.”

LifeCare Alliance, Ohio State collaborate to advance cancer health equity

LifeCare Alliance and the Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Center and Richard J. Solove Research Institute announced a partnership aimed at enhancing access to breast cancer screening and diagnostics for underserved individuals across Ohio.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Vaping and smoking together increases lung cancer risk fourfold

People who both vape and smoke are four times more likely to develop lung cancer than people who just smoke, according to a new study published by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and College of Public Health.

August 02, 2024

Vol.50 No.31

In Brief

Glen Barber named director of Center for Innate Immunity and Inflammation at Ohio State’s Pelotonia Institute for Immuno-Oncology

Glen Barber was named director of the Center for Innate Immunity and Inflammation within the Pelotonia Institute for Immuno-Oncology at the Ohio State University Comprehensive Cancer Center—James Cancer Hospital and Solove Research Institute.

July 12, 2024

Vol.50 No.28

Fatemeh Ardeshir, Andrew Srisuwananukorn receive ECOG-ACRIN Awards of Distinction

YOU MAY BE INTERESTED IN

ECOG-ACRIN, Caris collaborate on interrogating TAILORx breast cancer trial

Randomized trial failed to accrue, but data point to preoperative chemo as viable option in sinonasal cancer

Group chairs propose funding strategy to jump-start correlative studies

LifeCare Alliance, Ohio State collaborate to advance cancer health equity

Vaping and smoking together increases lung cancer risk fourfold

Glen Barber named director of Center for Innate Immunity and Inflammation at Ohio State’s Pelotonia Institute for Immuno-Oncology

Renew today!

Subscriber content

Login